Mini-Focus: Guideline-Directed Medical Therapy (GDMT)JACC: Heart Failure Expert Panel PaperTreatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory
JACC: Heart Failure Expert Panel Paper
Under a Creative Commons license
open access
Central Illustration
Key Words
clinical trials
heart failure
implementation science
Abbreviations and Acronyms
ACE
angiotensin-converting enzyme
ARB
angiotensin receptor blocker
ARNI
angiotensin receptor neprilysin inhibitor
GDMT
guideline-directed medical therapy
HF
heart failure
LVEF
left ventricular ejection fraction
MRA
mineralocorticoid receptor antagonist
SGLT2
sodium-glucose cotransporter 2
Cited by (0)
The views expressed in this paper are those of the authors and do not necessarily represent the views of the U.S. Food and Drug Administration or the United States Department of Health and Human Services. Barry Greenberg, MD, served as Guest Editor for this paper.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2021 The Author(s). Published by Elsevier on behalf of the American College of Cardiology Foundation.